Literature DB >> 23023295

Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells.

Kayo Hasehira1, Hiroaki Tateno, Yasuko Onuma, Yuzuru Ito, Makoto Asashima, Jun Hirabayashi.   

Abstract

We recently reported that induced pluripotent stem cells (iPSCs) prepared from different human origins acquired similar glycan profiles to one another as well as to human embryonic stem cells. Although the results strongly suggested attainment of specific glycan expressions associated with the acquisition of pluripotency, the detailed glycan structures remained to be elucidated. Here, we perform a quantitative glycome analysis targeting both N- and O-linked glycans derived from 201B7 human iPSCs and human dermal fibroblasts as undifferentiated and differentiated cells, respectively. Overall, the fractions of high mannose-type N-linked glycans were significantly increased upon induction of pluripotency. Moreover, it became evident that the type of linkage of Sia on N-linked glycans was dramatically changed from α-2-3 to α-2-6, and the expression of α-1-2 fucose and type 1 LacNAc structures became clearly apparent, while no such glycan epitopes were detected in fibroblasts. The expression profiles of relevant glycosyltransferase genes were fully consistent with these results. These observations indicate unambiguously the manifestation of a "glycome shift" upon conversion to iPSCs, which may not merely be the result of the initialization of gene expression, but could be involved in a more aggressive manner either in the acquisition or maintenance of the undifferentiated state of iPSCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023295      PMCID: PMC3518133          DOI: 10.1074/mcp.M112.020586

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  36 in total

1.  The Galβ-(syn)-gauche configuration is required for galectin-recognition disaccharides.

Authors:  Jun Iwaki; Hiroaki Tateno; Nozomu Nishi; Toshikazu Minamisawa; Sachiko Nakamura-Tsuruta; Yoko Itakura; Junko Kominami; Tadasu Urashima; Takanori Nakamura; Jun Hirabayashi
Journal:  Biochim Biophys Acta       Date:  2011-04-15

2.  Lectin microarray analysis of pluripotent and multipotent stem cells.

Authors:  Masashi Toyoda; Mayu Yamazaki-Inoue; Yoko Itakura; Atsushi Kuno; Tomohisa Ogawa; Masao Yamada; Hidenori Akutsu; Yuji Takahashi; Seiichi Kanzaki; Hisashi Narimatsu; Jun Hirabayashi; Akihiro Umezawa
Journal:  Genes Cells       Date:  2010-12-13       Impact factor: 1.891

Review 3.  The use of induced pluripotent stem cells in drug development.

Authors:  H Inoue; S Yamanaka
Journal:  Clin Pharmacol Ther       Date:  2011-03-23       Impact factor: 6.875

4.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

Authors:  S Tamir Rashid; Sebastien Corbineau; Nick Hannan; Stefan J Marciniak; Elena Miranda; Graeme Alexander; Isabel Huang-Doran; Julian Griffin; Lars Ahrlund-Richter; Jeremy Skepper; Robert Semple; Anne Weber; David A Lomas; Ludovic Vallier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

5.  Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis.

Authors:  Ya Zhuo; Roger Chammas; Susan L Bellis
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

Review 8.  The glycans of stem cells.

Authors:  Pascal M Lanctot; Fred H Gage; Ajit P Varki
Journal:  Curr Opin Chem Biol       Date:  2007-07-27       Impact factor: 8.822

9.  The N-glycome of human embryonic stem cells.

Authors:  Tero Satomaa; Annamari Heiskanen; Milla Mikkola; Cia Olsson; Maria Blomqvist; Minna Tiittanen; Taina Jaatinen; Olli Aitio; Anne Olonen; Jari Helin; Jukka Hiltunen; Jari Natunen; Timo Tuuri; Timo Otonkoski; Juhani Saarinen; Jarmo Laine
Journal:  BMC Cell Biol       Date:  2009-06-02       Impact factor: 4.241

10.  Generation of functional eyes from pluripotent cells.

Authors:  Andrea S Viczian; Eduardo C Solessio; Yung Lyou; Michael E Zuber
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

View more
  38 in total

Review 1.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-01-11       Impact factor: 2.916

Review 2.  Glycomics of human embryonic stem cells and human induced pluripotent stem cells.

Authors:  Jun-Ichi Furukawa; Kazue Okada; Yasuro Shinohara
Journal:  Glycoconj J       Date:  2016-06-18       Impact factor: 2.916

Review 3.  Glycomics of human embryonic stem cells and human induced pluripotent stem cells.

Authors:  Jun-Ichi Furukawa; Kazue Okada; Yasuro Shinohara
Journal:  Glycoconj J       Date:  2017-11-18       Impact factor: 2.916

Review 4.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

5.  Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.

Authors:  Zheng Cao; Kevin Maupin; Bryan Curnutte; Brian Fallon; Christa L Feasley; Elizabeth Brouhard; Richard Kwon; Christopher M West; John Cunningham; Randall Brand; Paola Castelli; Stefano Crippa; Ziding Feng; Peter Allen; Diane M Simeone; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2013-07-08       Impact factor: 5.911

Review 6.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

7.  Insights into miRNA regulation of the human glycome.

Authors:  Brian T Kasper; Sujeethraj Koppolu; Lara K Mahal
Journal:  Biochem Biophys Res Commun       Date:  2014-01-23       Impact factor: 3.575

8.  Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.

Authors:  Hiroaki Tateno; Asako Matsushima; Keiko Hiemori; Yasuko Onuma; Yuzuru Ito; Kayo Hasehira; Ken Nishimura; Manami Ohtaka; Satoko Takayasu; Mahito Nakanishi; Yuzuru Ikehara; Mio Nakanishi; Kiyoshi Ohnuma; Techuan Chan; Masashi Toyoda; Hidenori Akutsu; Akihiro Umezawa; Makoto Asashima; Jun Hirabayashi
Journal:  Stem Cells Transl Med       Date:  2013-03-22       Impact factor: 6.940

9.  ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.

Authors:  Amanda F Swindall; Angelina I Londoño-Joshi; Matthew J Schultz; Naomi Fineberg; Donald J Buchsbaum; Susan L Bellis
Journal:  Cancer Res       Date:  2013-01-28       Impact factor: 12.701

10.  Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.

Authors:  Katie L Alexander; Carolina A Serrano; Asmi Chakraborty; Marie Nearing; Leona N Council; Arnoldo Riquelme; Marcelo Garrido; Susan L Bellis; Lesley E Smythies; Phillip D Smith
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.